Related Experiment Videos
Atypical cytogenic aberrations in two childhood peripheral primitive neuroectodermal tumors
J C Murray1, C Langston, Z E Dreyer
1Section of Hematology-Oncology, Texas Children's Cancer Center, Houston.
Genes, Chromosomes & Cancer
|February 1, 1995
Summary
Atypical genetic changes in pediatric peripheral primitive neuroectodermal tumors (PPNET) were observed. These findings suggest PPNET may have diverse genetic profiles, unlike typical Ewing sarcoma.
Area of Science:
- Pediatric Oncology
- Cytogenetics
- Molecular Biology
Background:
- Peripheral primitive neuroectodermal tumors (PPNET) are rare pediatric malignancies.
- Standard cytogenetic analysis, particularly the t(11;22) translocation, is crucial for diagnosing Ewing sarcoma and PPNET.
- Understanding the genetic landscape of PPNET is essential for targeted therapies.
Observation:
- Two pediatric cases of PPNET with atypical cytogenetic abnormalities were analyzed.
- Case 1: Osseous PPNET with t(5;9)(q22;q32) showed a complete therapeutic response.
- Case 2: Non-osseous PPNET with del(18)(q12.2q21.2) exhibited resistance to therapy and potential clonal evolution.
Findings:
- Neither PPNET case presented the characteristic t(11;22)(q24;q12) translocation.
- The observed translocations and deletions indicate significant cytogenetic heterogeneity within PPNET.
- Clonal evolution may contribute to therapeutic resistance in PPNET.
Implications:
- The diverse genetic aberrations in PPNET suggest a need for individualized diagnostic and therapeutic strategies.
- These findings challenge the notion of a single cytogenetic profile for PPNET.
- Further research into PPNET genetics could reveal novel therapeutic targets for this rare cancer.